
  
    
      
        Background_NNP
        The_DT tumor_NN suppressor_NN gene_NN PTEN_NNP (_( also_RB called_VBN MMAC_NNP 1_LS )_) has_VBZ
        been_VBN found_VBN deleted_VBN or_CC mutated_VBN in_IN a_DT great_JJ variety_NN of_IN human_JJ
        tumors_NNS and_CC tumor_NN cell_NN lines_NNS [_NN 1_CD 2_CD 3_CD ]_NN ,_, and_CC its_PRP$ tumor_NN
        suppressing_VBG function_NN has_VBZ been_VBN confirmed_VBN in_IN several_JJ 
        in_IN vitro_NN studies_NNS [_NN 4_CD 5_CD 6_CD 7_CD 8_CD 9_CD 10_CD ]_NN ._.
        Mice_NNS which_WDT are_VBP homozygously_RB deficient_NN in_IN wild-type_JJ PTEN_NNP die_VB
        during_IN embryonic_JJ development_NN and_CC harbor_NN regions_NNS of_IN
        increased_VBN cellular_JJ proliferation_NN ,_, whereas_IN heterozygous_JJ mice_NNS
        are_VBP viable_JJ but_CC spontaneously_RB develop_VB tumors_NNS of_IN various_JJ
        origins_NNS [_NN 11_CD 12_CD ]_NN ._.
        PTEN_NNP has_VBZ been_VBN shown_VBN to_TO exhibit_VB dual_JJ specificity_NN protein_NN
        phosphatase_NN activity_NN ,_, as_RB well_RB as_IN lipid_NN phosphatase_NN activity_NN
        
        in_IN vitro_NN [_NN 13_CD 14_CD 15_CD 16_CD 17_CD 18_CD ]_NN ._.
        These_DT enzymatic_JJ functions_NNS appear_VBP to_TO be_VB involved_VBN in_IN the_DT
        regulation_NN of_IN at_IN least_JJS two_CD separate_JJ signal_NN transduction_NN
        pathways_NNS ._. First_LS ,_, PTEN_NNP 's_POS protein_NN phosphatase_NN activity_NN is_VBZ
        able_JJ to_TO down-regulate_JJ focal_JJ adhesion_NN kinase_NN (_( FAK_NNP )_)
        phosphorylation_NN ,_, which_WDT leads_VBZ to_TO the_DT inactivation_NN of_IN the_DT
        Ras_NNP /_NN MAP_NNP kinase_NN pathway_NN [_NN 19_CD 20_CD 21_CD ]_NN ._. Second_JJ ,_, its_PRP$ lipid_NN
        phosphatase_NN activity_NN targets_VBZ the_DT second_JJ messenger_NN
        phosphatidylinositol_NN 3_CD ,_, 4_CD ,_, 5_CD -_: trisphosphate_NN [_NN PtdIns_NNP (_( 3_CD ,_, 4_CD ,_, 5_LS )_) P_NN 
        3_CD ]_NN and_CC thereby_RB blocks_VBZ activation_NN of_IN the_DT
        protein_NN kinase_NN B_NNP (_( PKB_NNP /_NN Akt_NNP )_) pathway_NN [_NN 11_CD 18_CD 22_CD 23_CD 24_CD ]_NN ._.
        Whereas_IN both_DT of_IN the_DT above_JJ pathways_NNS are_VBP intimately_RB involved_VBN
        in_IN the_DT control_NN of_IN cell_NN growth_NN and_CC survival_NN ,_, PTEN-regulated_NNP
        FAK_NNP activity_NN further_JJ appears_VBZ to_TO impinge_NN on_IN cell_NN adhesion_NN ,_,
        cell_NN migration_NN ,_, and_CC cell_NN invasion_NN [_NN 20_CD 21_CD ]_NN ._. It_PRP therefore_RB
        emerges_VBZ that_IN the_DT loss_NN of_IN PTEN_NNP activity_NN may_MD confer_VB increased_VBN
        survival_NN ability_NN ,_, proliferative_JJ potential_NN ,_, and_CC invasive_JJ
        capacity_NN on_IN cells_NNS ,_, and_CC thereby_RB may_MD promote_VB progression_NN
        towards_IN a_DT more_RBR malignant_JJ phenotype_NN ._.
        A_DT characteristic_JJ phenotype_NN of_IN tumorigenic_JJ cells_NNS is_VBZ their_PRP$
        ability_NN to_TO grow_VB anchorage-independently_JJ in_IN suspension_NN
        culture_NN ,_, or_CC embedded_VBN in_IN soft_JJ agar_NN ,_, without_IN the_DT need_NN for_IN
        attachment_NN to_TO the_DT surface_NN of_IN a_DT cell_NN culture_NN dish_NN [_NN 25_CD 26_CD ]_NN
        ._. A_DT flurry_NN of_IN papers_NNS has_VBZ established_VBN a_DT close_JJ link_NN between_IN
        anchorage-independent_JJ growth_NN and_CC the_DT activity_NN of_IN several_JJ
        components_NNS of_IN the_DT cell_NN cycle_NN machinery_NN ,_, such_JJ as_IN various_JJ
        cyclins_NNS ,_, cyclin-dependent_JJ kinases_NNS (_( CDKs_NNP )_) ,_, and_CC the_DT CDK_NNP
        inhibitors_NNS p_NN 21_CD Cip_NNP 1_CD and_CC p_NN 27_CD Kip_NNP 1_CD [_NN 27_CD 28_CD 29_CD 30_CD 31_CD 32_CD ]_NN ._.
        There_EX are_VBP indications_NNS that_IN PTEN_NNP may_MD be_VB involved_VBN in_IN these_DT
        processes_VBZ as_RB well_RB ._. For_IN example_NN ,_, mouse_NN embryonal_NN stem_NN (_( ES_NNP )_)
        cells_NNS with_IN homozygous_JJ deletion_NN of_IN the_DT PTEN_NNP gene_NN exhibit_NN
        increased_VBD anchorage-independent_JJ growth_NN as_IN compared_VBN to_TO
        normal_JJ ES_NNP cells_NNS [_NN 12_CD ]_NN ._. Similarly_RB ,_, transfer_NN of_IN a_DT wild_JJ type_NN
        PTEN_NNP gene_NN into_IN anchorage-independent_JJ human_JJ glioblastoma_NN
        cells_NNS (_( which_WDT lack_VBP functional_JJ PTEN_NNP )_) ,_, results_NNS in_IN their_PRP$
        greatly_RB reduced_VBN ability_NN to_TO form_VB colonies_NNS in_IN soft_JJ agar_NN [_NN 4_CD 5_CD
        6_CD ]_NN ._. The_DT interpretation_NN of_IN these_DT latter_JJ findings_NNS ,_, however_RB ,_,
        is_VBZ complicated_VBN by_IN the_DT strong_JJ anti-proliferative_JJ effects_NNS of_IN
        PTEN_NNP even_RB in_IN monolayer_NN culture_NN ,_, which_WDT is_VBZ consistently_RB
        observed_VBN when_WRB the_DT wild_JJ type_NN version_NN of_IN this_DT gene_NN is_VBZ
        introduced_VBN into_IN PTEN-negative_NNP tumor_NN cells_NNS [_NN 4_CD 6_CD 7_CD 8_CD 9_CD 10_CD 18_CD
        33_CD ]_NN ._. Moreover_RB ,_, in_IN human_JJ glioma_NN and_CC breast_NN cancer_NN cell_NN
        lines_NNS ,_, the_DT ectopic_JJ expression_NN of_IN wild_JJ type_NN PTEN_NNP leads_VBZ to_TO
        anoikis_NNS ,_, which_WDT is_VBZ apoptosis_NNS initiated_VBN by_IN the_DT disruption_NN of_IN
        cell_NN matrix-interactions_JJ [_NN 23_CD 34_CD 35_CD 36_CD ]_NN ._.
        Because_IN essentially_RB all_DT of_IN these_DT previous_JJ studies_NNS have_VBP
        analyzed_VBN PTEN_NNP function_NN by_IN introducing_VBG the_DT cloned_VBN version_NN of_IN
        the_DT gene_NN back_RB into_IN PTEN-deficient_NNP cells_NNS ,_, essentially_RB
        nothing_NN is_VBZ known_VBN about_IN the_DT regulation_NN of_IN the_DT endogenous_JJ
        PTEN_NNP gene_NN in_IN response_NN to_TO alterations_NNS of_IN cell-matrix_JJ
        interactions_NNS ._. For_IN example_NN ,_, it_PRP is_VBZ unclear_JJ whether_IN PTEN_NNP is_VBZ
        constitutively_RB active_JJ or_CC becomes_VBZ activated_VBN in_IN response_NN to_TO
        changes_NNS in_IN the_DT cellular_JJ microenvironment_NN ._. Here_RB ,_, we_PRP present_JJ
        our_PRP$ findings_NNS that_IN in_IN normal_JJ anchorage-dependent_JJ fibroblast_NN
        cells_NNS ,_, the_DT expression_NN and_CC activity_NN of_IN endogenous_JJ PTEN_NNP is_VBZ
        increased_VBN when_WRB cellular_JJ adhesion_NN to_TO matrix_NN is_VBZ disrupted_VBN ._. In_IN
        parallel_JJ ,_, phosphorylation_NN of_IN FAK_NNP ,_, a_DT known_VBN target_NN of_IN PTEN_NNP ,_,
        is_VBZ greatly_RB reduced_VBN ._. In_IN view_NN of_IN PTEN_NNP 's_POS potent_JJ
        growth-inhibitory_JJ capacity_NN ,_, we_PRP conclude_VBP from_IN our_PRP$ study_NN that_IN
        the_DT increased_VBN expression_NN and_CC activity_NN of_IN endogenous_JJ PTEN_NNP in_IN
        response_NN to_TO the_DT disruption_NN of_IN cell-matrix_JJ interactions_NNS
        contributes_VBZ to_TO the_DT maintenance_NN of_IN the_DT anchorage-dependent_JJ
        phenotype_NN of_IN normal_JJ cells_NNS ._.
      
      
        Results_NNS
        A_DT model_NN to_TO study_VB cell_NN regulatory_JJ events_NNS during_IN
        anchorage-independent_JJ growth_NN is_VBZ the_DT culture_NN of_IN cells_NNS in_IN
        suspension_NN ,_, i_NNP ._. e_SYM ._. on_IN HEMA-coated_NNP plates_NNS that_WDT prevent_VBP cells_NNS
        from_IN attachment_NN to_TO the_DT matrix_NN of_IN the_DT cell_NN culture_NN dish_NN [_NN 37_CD
        ]_NN ._. Several_JJ studies_NNS have_VBP employed_VBN this_DT approach_NN and_CC
        characterized_VBD the_DT regulation_NN of_IN various_JJ cell_NN
        cycle-regulatory_JJ proteins_NNS after_IN the_DT transfer_NN of_IN cells_NNS to_TO
        such_JJ suspension_NN culture_NN [_NN 27_CD 28_CD 29_CD 30_CD 31_CD 32_CD ]_NN ._. Here_RB ,_, we_PRP
        have_VBP used_VBN this_DT model_NN to_TO analyze_VB the_DT potential_JJ involvement_NN
        of_IN the_DT tumor_NN suppressor_NN PTEN_NNP ._.
        The_DT murine_NN cell_NN line_NN 10_CD T_NN 1_CD /_NN 2_CD and_CC the_DT human_JJ cell_NN line_NN
        MDAH_NNP ,_, both_DT of_IN which_WDT are_VBP anchorage-dependent_JJ fibroblasts_NNS ,_,
        were_VBD detached_VBN from_IN their_PRP$ tissue_NN culture_NN dishes_NNS and_CC cultured_JJ
        further_RB on_IN HEMA-coated_NNP plates_NNS ._. As_IN shown_VBN in_IN Figure_NN 1_CD ,_, this_DT
        transfer_NN to_TO suspension_NN culture_NN resulted_VBD in_IN elevated_JJ
        expression_NN of_IN PTEN_NNP protein_NN in_IN each_DT cell_NN line_NN ._. This_DT increase_NN
        was_VBD apparent_JJ within_IN the_DT first_JJ four_CD hours_NNS and_CC continued_VBD for_IN
        several_JJ more_JJR hours_NNS ._. In_IN parallel_JJ ,_, the_DT expression_NN of_IN cyclin_NN
        A_DT ,_, an_DT essential_JJ component_NN of_IN certain_JJ cyclin-dependent_JJ
        kinases_NNS and_CC absolutely_RB required_VBN for_IN the_DT progression_NN of_IN
        cells_NNS through_IN the_DT cell_NN cycle_NN [_NN 38_CD 39_CD ]_NN ,_, was_VBD down-regulated_JJ
        under_IN these_DT conditions_NNS (_( Figure_NN 1_LS )_) ,_, consistent_JJ with_IN earlier_JJR
        observations_NNS [_NN 27_CD 28_CD 31_CD ]_NN ._. Furthermore_RB ,_, expression_NN of_IN the_DT
        CDK_NNP inhibitor_NN p_NN 27_CD Kip_NNP 1_CD was_VBD strongly_RB increased_VBN in_IN suspension_NN
        cells_NNS (_( Figure_NN 1_LS )_) ,_, similar_JJ to_TO what_WP has_VBZ been_VBN observed_VBN in_IN
        other_JJ cell_NN types_NNS after_IN the_DT disruption_NN of_IN cell-matrix_JJ
        interactions_NNS [_NN 29_CD 31_CD 32_CD ]_NN ._. Finally_RB ,_, as_IN we_PRP have_VBP reported_VBN
        before_IN [_NN 31_CD ]_NN ,_, the_DT expression_NN of_IN cdk_NN 4_CD ,_, one_CD of_IN the_DT
        catalytic_JJ subunits_NNS of_IN CDKs_NNP ,_, was_VBD not_RB significantly_RB altered_VBN
        in_IN suspension_NN culture_NN cells_NNS and_CC therefore_RB could_MD be_VB used_VBN as_IN
        a_DT loading_NN control_NN for_IN the_DT Western_JJ blot_NN analysis_NN ._. As_IN
        expected_VBN in_IN the_DT case_NN of_IN anchorage-dependent_JJ cells_NNS ,_, the_DT
        activity_NN of_IN cyclin-dependent_JJ kinases_NNS was_VBD strongly_RB reduced_VBN
        and_CC cell_NN proliferation_NN was_VBD inhibited_VBD under_IN these_DT suspension_NN
        culture_NN conditions_NNS (_( not_RB shown_VBN )_) ._.
        To_TO analyze_VB whether_IN the_DT observed_VBN induction_NN of_IN PTEN_NNP
        protein_NN was_VBD due_JJ to_TO elevated_VBD expression_NN of_IN its_PRP$ mRNA_NN ,_,
        Northern_NNP blot_NN analysis_NN was_VBD performed_VBN ._. In_IN this_DT case_NN ,_,
        increased_VBN expression_NN was_VBD found_VBN as_RB well_RB (_( Figure_NN 2_LS )_) ._. In_IN MDAH_NNP
        cells_NNS in_IN particular_JJ ,_, the_DT increase_NN in_IN PTEN_NNP mRNA_NN closely_RB
        correlated_JJ with_IN the_DT observed_VBN increase_NN in_IN PTEN_NNP protein_NN and_CC
        encompassed_VBD both_DT major_JJ mRNA_NN species_NNS of_IN 2_CD ._. 5_CD and_CC 5_CD ._. 0_CD kb_NN ._. In_IN
        the_DT mouse_NN cells_NNS ,_, only_RB the_DT shorter_JJR mRNA_NN species_NNS appeared_VBD to_TO
        be_VB induced_VBN ._. In_IN order_NN to_TO determine_VB the_DT relative_JJ increase_NN in_IN
        PTEN_NNP mRNA_NN levels_NNS ,_, the_DT Northern_NNP blots_NNS were_VBD stripped_VBN and_CC
        re-hybridized_JJ with_IN control_NN probes_NNS for_IN β-actin_JJ and_CC choA_NN ,_, the_DT
        latter_JJ a_DT highly_RB abundant_JJ mRNA_NN of_IN unknown_JJ function_NN [_NN 40_CD ]_NN ._.
        We_PRP consistently_RB found_VBD that_IN the_DT amount_NN of_IN β-actin_JJ mRNA_NN was_VBD
        somewhat_RB reduced_VBN during_IN suspension_NN culture_NN ,_, whereas_IN the_DT
        amount_NN of_IN choA_NN remained_VBD relatively_RB stable_JJ ._. We_PRP therefore_RB
        used_VBD choA_NN as_IN the_DT loading_NN control_NN and_CC calculated_VBD the_DT
        increase_NN in_IN PTEN_NNP mRNA_NN with_IN reference_NN to_TO choA_NN ._. Using_VBG this_DT
        approach_NN ,_, we_PRP determined_VBD that_IN PTEN_NNP mRNA_NN was_VBD increased_VBN up_IN to_TO
        5_CD -_: fold_VB in_IN MDAH_NNP cells_NNS and_CC 4_CD -_: fold_VB in_IN 10_CD T_NN 1_CD /_NN 2_CD cells_NNS ._. This_DT
        induction_NN was_VBD comparable_JJ to_TO the_DT increase_NN observed_VBD in_IN
        Western_JJ blot_NN analysis_NN and_CC therefore_RB indicated_VBD that_IN the_DT
        levels_NNS of_IN PTEN_NNP protein_NN were_VBD elevated_VBD due_JJ to_TO the_DT increased_VBN
        expression_NN of_IN PTEN_NNP mRNA_NN ._. Although_IN clearly_RB induced_VBN in_IN both_DT
        cell_NN lines_NNS ,_, the_DT kinetics_NNS of_IN PTEN_NNP induction_NN in_IN 10_CD T_NN 1_CD /_NN 2_CD and_CC
        MDAH_NNP cells_NNS were_VBD somewhat_RB different_JJ at_IN later_RB time_NN points_NNS ;_:
        i_NNP ._. e_SYM ._. ,_, there_EX was_VBD a_DT slight_JJ reduction_NN of_IN PTEN_NNP mRNA_NN and_CC protein_NN
        in_IN MDAH_NNP cells_NNS at_IN 36_CD hours_NNS ,_, possibly_RB indicating_VBG some_DT cell_NN
        type-specific_JJ differences_NNS ._.
        By_IN using_VBG nuclear_JJ run-off_JJ analysis_NN ,_, we_PRP further_RBR determined_VBN
        that_IN the_DT induction_NN of_IN PTEN_NNP was_VBD regulated_VBN at_IN the_DT
        transcriptional_NN level_NN ,_, i_NNP ._. e_SYM ._. the_DT transcription_NN of_IN the_DT PTEN_NNP
        gene_NN was_VBD significantly_RB higher_JJR in_IN cells_NNS that_WDT were_VBD
        transferred_VBN to_TO suspension_NN culture_NN conditions_NNS (_( Figure_NN
        3_LS )_) ._.
        We_PRP next_RB analyzed_VBD whether_IN the_DT elevated_VBD quantity_NN of_IN PTEN_NNP
        protein_NN would_MD indeed_RB be_VB reflected_VBN in_IN increased_VBN phosphatase_NN
        activity_NN in_IN suspension_NN culture_NN cells_NNS ._. In_IN order_NN to_TO establish_VB
        whether_IN PTEN_NNP protein_NN phosphatase_NN activity_NN could_MD be_VB reliably_RB
        measured_VBN in_IN vitro_NN ,_, we_PRP first_JJ transfected_JJ PTEN-negative_NNP U_NNP 87_CD
        cells_NNS with_IN an_DT expression_NN vector_NN harboring_VBG PTEN_NNP cDNA_NN ._. As_IN a_DT
        control_NN ,_, the_DT cells_NNS were_VBD also_RB transfected_JJ with_IN empty_JJ vector_NN ._.
        Then_RB ,_, PTEN_NNP was_VBD immunoprecipitated_JJ from_IN the_DT respective_JJ
        cellular_JJ lysates_NNS and_CC the_DT antigen-antibody_JJ complex_NN was_VBD
        analyzed_VBN for_IN protein_NN phosphatase_NN activity_NN ._. As_IN shown_VBN in_IN
        Figure_NN 4_CD A_DT ,_, only_RB cells_NNS transfected_JJ with_IN PTEN_NNP cDNA_NN exhibited_VBN
        significant_JJ enzymatic_JJ activity_NN ._. Non-transfected_NNP U_NNP 87_CD cells_NNS ,_,
        or_CC cells_NNS transfected_JJ with_IN vector_NN alone_RB ,_, did_VBD not_RB exhibit_VB
        protein_NN phosphatase_NN activity_NN above_IN background_NN levels_NNS ._.
        After_IN having_VBG established_VBN that_IN PTEN_NNP protein_NN phosphatase_NN
        activity_NN could_MD be_VB determined_VBN specifically_RB ,_, we_PRP transferred_VBD
        MDAH_NNP cells_NNS to_TO suspension_NN culture_NN conditions_NNS and_CC measured_VBN
        PTEN_NNP activity_NN at_IN various_JJ times_NNS afterwards_RB ._. As_IN shown_VBN in_IN
        Figure_NN 4_CD B_NNP ,_, there_EX was_VBD an_DT increase_NN in_IN PTEN_NNP activity_NN that_WDT
        could_MD be_VB detected_VBN as_RB early_RB as_IN four_CD hours_NNS after_IN detachment_NN
        and_CC reached_VBD its_PRP$ maximum_NN at_IN around_IN 12_CD hours_NNS ._. It_PRP is_VBZ
        noticeable_JJ that_IN the_DT activity_NN at_IN the_DT onset_NN of_IN the_DT experiment_NN
        (_( 0_CD hours_NNS ,_, cells_NNS attached_VBN to_TO tissue_NN culture_NN plates_NNS )_) was_VBD
        higher_JJR than_IN background_NN ,_, which_WDT likely_JJ indicates_VBZ some_DT basal_NN
        activity_NN of_IN PTEN_NNP in_IN attached_VBN cells_NNS ._. This_DT basal_NN level_NN
        activity_NN was_VBD not_RB detectable_JJ in_IN PTEN-negative_NNP U_NNP 87_CD cells_NNS
        (_( compare_VB Figure_NN 4_CD A_DT )_) ._.
        Focal_NNP adhesion_NN kinase_NN (_( FAK_NNP )_) is_VBZ a_DT known_VBN substrate_NN for_IN
        PTEN_NNP and_CC has_VBZ been_VBN shown_VBN to_TO be_VB dephosphorylated_JJ by_IN this_DT
        phosphatase_NN in_IN vitro_NN and_CC in_IN vivo_NN [_NN 20_CD 21_CD 34_CD ]_NN ._. We_PRP
        therefore_RB determined_VBD whether_IN the_DT increased_VBN PTEN_NNP phosphatase_NN
        activity_NN would_MD correlate_VBP with_IN decreased_VBN phosphorylation_NN of_IN
        FAK_NNP in_IN our_PRP$ cells_NNS ._. This_DT was_VBD indeed_RB the_DT case_NN ._. As_IN shown_VBN in_IN
        Figure_NN 5_CD ,_, the_DT detachment_NN of_IN MDAH_NNP cells_NNS from_IN their_PRP$ matrix_NN
        resulted_VBD in_IN decreased_VBD tyrosine-specific_JJ phosphorylation_NN of_IN
        FAK_NNP ._. The_DT overall_JJ amount_NN of_IN FAK_NNP protein_NN in_IN these_DT cells_NNS did_VBD
        not_RB change_VB under_IN these_DT conditions_NNS ,_, indicating_VBG that_IN the_DT loss_NN
        of_IN tyrosine_NN phosphorylation_NN was_VBD not_RB caused_VBN by_IN reduced_VBN
        amounts_NNS of_IN protein_NN ._.
        In_IN light_NN of_IN a_DT recent_JJ report_NN establishing_VBG the_DT tumor_NN
        suppressor_NN p_NN 53_CD as_IN a_DT transcriptional_NN activator_NN of_IN PTEN_NNP
        expression_NN [_NN 41_CD ]_NN ,_, we_PRP investigated_VBD whether_IN this_DT protein_NN
        would_MD affect_VB the_DT observed_VBN induction_NN of_IN PTEN_NNP in_IN our_PRP$ cell_NN
        system_NN ._. As_IN MDAH_NNP cells_NNS themselves_PRP are_VBP p_NN 53_CD -_: negative_JJ ,_, we_PRP used_VBD
        MDAH_NNP cells_NNS stably_RB transfected_JJ with_IN a_DT tetracycline-regulated_JJ
        p_NN 53_CD gene_NN ,_, called_VBD TR_NNP 9_CD -_: 7_CD [_NN 42_CD ]_NN ._. These_DT TR_NNP 9_CD -_: 7_CD cells_NNS were_VBD
        pre-treated_JJ with_IN or_CC without_IN tetracycline_NN in_IN monolayer_NN
        culture_NN ._. After_IN the_DT induction_NN of_IN p_NN 53_CD was_VBD maximal_NN ,_, the_DT cells_NNS
        were_VBD transferred_VBN to_TO suspension_NN culture_NN conditions_NNS and_CC
        analyzed_VBD for_IN their_PRP$ expression_NN of_IN PTEN_NNP ._. As_IN shown_VBN in_IN Figure_NN
        6_CD ,_, the_DT degree_NN of_IN PTEN_NNP induction_NN was_VBD essentially_RB the_DT same_JJ in_IN
        the_DT absence_NN or_CC presence_NN of_IN p_NN 53_CD ,_, indicating_VBG that_DT p_NN 53_CD did_VBD not_RB
        affect_VB the_DT induction_NN of_IN PTEN_NNP protein_NN under_IN these_DT
        conditions_NNS ._. In_IN parallel_JJ ,_, MDAH_NNP cells_NNS were_VBD also_RB treated_VBN with_IN
        tetracycline_NN and_CC transferred_VBN to_TO suspension_NN culture_NN ._. In_IN this_DT
        case_NN as_IN well_RB ,_, tetracycline_NN treatment_NN had_VBD no_DT effect_NN on_IN the_DT
        induction_NN of_IN PTEN_NNP ,_, confirming_VBG that_DT tetracycline_NN by_IN itself_PRP
        did_VBD not_RB affect_VB PTEN_NNP expression_NN (_( Figure_NN 6_CD )_) ._. In_IN conclusion_NN ,_,
        MDAH_NNP cells_NNS (_( p_NN 53_CD -_: negative_JJ )_) ,_, 10_CD T_NN 1_CD /_NN 2_CD cells_NNS (_( p_NN 53_CD -_: positive_JJ )_) ,_, and_CC
        TR_NNP 9_CD -_: 7_CD cells_NNS (_( high_JJ or_CC low_JJ levels_NNS of_IN p_NN 53_CD )_) all_DT exhibited_VBN
        similarly_RB increased_VBN expression_NN levels_NNS of_IN PTEN_NNP in_IN response_NN
        to_TO the_DT disruption_NN of_IN cell-matrix_JJ interactions_NNS ._. Therefore_RB ,_,
        we_PRP conclude_VBP that_IN the_DT observed_VBN induction_NN of_IN PTEN_NNP occurs_VBZ
        independent_JJ of_IN p_NN 53_CD ._.
      
      
        Discussion_NNP
        In_IN light_NN of_IN the_DT close_JJ correlation_NN between_IN the_DT
        anchorage-independent_JJ phenotype_NN and_CC the_DT tumorigenicity_NN of_IN
        transformed_VBN cells_NNS ,_, it_PRP is_VBZ important_JJ to_TO fully_RB understand_VB the_DT
        cellular_JJ mechanisms_NNS that_WDT are_VBP involved_VBN in_IN cell_NN growth_NN arrest_NN
        after_IN the_DT disruption_NN of_IN cell-matrix_JJ interactions_NNS ._. Many_JJ
        previous_JJ studies_NNS in_IN this_DT area_NN have_VBP focused_VBN on_IN the_DT
        contribution_NN of_IN various_JJ components_NNS of_IN the_DT cell_NN cycle_NN
        machinery_NN ._. Collectively_RB ,_, they_PRP have_VBP established_VBN that_IN the_DT
        expression_NN of_IN cyclin_NN A_DT and_CC cyclin_NN D_NNP ,_, in_IN combination_NN with_IN
        the_DT activity_NN of_IN the_DT cyclin-dependent_JJ kinase_NN inhibitors_NNS p_NN 21_CD
        Cip_NNP 1_CD and_CC p_NN 27_CD Kip_NNP 1_CD ,_, is_VBZ a_DT crucial_JJ determinant_NN of_IN
        anchorage-dependent_JJ cell_NN growth_NN culture_NN [_NN 27_CD 28_CD 29_CD 30_CD 31_CD 32_CD
        ]_NN ._. However_RB ,_, while_IN the_DT above_JJ elements_NNS clearly_RB are_VBP essential_JJ
        executioners_NNS of_IN cell_NN cycle_NN progression_NN ,_, it_PRP is_VBZ conceivable_JJ
        that_IN other_JJ elements_NNS ,_, directly_RB or_CC indirectly_RB ,_, might_MD be_VB
        involved_VBN in_IN anchorage-dependent_JJ growth_NN control_NN as_RB well_RB ._. In_IN
        this_DT regard_NN ,_, a_DT report_NN from_IN our_PRP$ laboratory_NN has_VBZ indicated_VBN a_DT
        role_NN for_IN the_DT serine_NN /_NN threonine_NN specific_JJ protein_NN phosphatase_NN
        type_NN 2_CD A_DT (_( PP_NNP 2_CD A_DT )_) [_NN 43_CD ]_NN ._.
        In_IN this_DT current_JJ study_NN ,_, we_PRP investigated_VBD the_DT response_NN of_IN
        the_DT PTEN_NNP tumor_NN suppressor_NN to_TO changes_NNS in_IN cell-matrix_JJ
        interactions_NNS of_IN anchorage-dependent_JJ human_NN and_CC mouse_NN
        fibroblast_NN cells_NNS ._. Previous_JJ studies_NNS by_IN others_NNS had_VBD shown_VBN that_IN
        the_DT ectopic_JJ expression_NN of_IN PTEN_NNP in_IN anchorage-independent_JJ
        tumor_NN cells_NNS greatly_RB reduced_VBN their_PRP$ ability_NN to_TO grow_VB in_IN soft_JJ
        agar_NN [_NN 4_CD 5_CD 6_CD ]_NN ._. In_IN this_DT latter_JJ situation_NN ,_, however_RB ,_, the_DT
        forced_VBN expression_NN of_IN ectopic_JJ PTEN_NNP effectively_RB impairs_NNS
        cellular_JJ proliferation_NN in_IN general_JJ ,_, even_RB under_IN
        two-dimensional_JJ culture_NN conditions_NNS where_WRB the_DT cells_NNS are_VBP
        attached_VBN to_TO substratum_NN [_NN 4_CD 6_CD 7_CD 8_CD 9_CD 10_CD 18_CD 33_CD 44_CD ]_NN ._. It_PRP was_VBD
        therefore_RB difficult_JJ to_TO discern_VB from_IN these_DT experiments_NNS how_WRB
        effectively_RB and_CC selectively_RB PTEN_NNP participates_VBZ in_IN
        anchorage-dependent_JJ growth_NN control_NN ._. As_IN an_DT alternative_NN to_TO
        the_DT forced_VBN expression_NN of_IN ectopic_JJ PTEN_NNP in_IN
        anchorage-independent_JJ ,_, PTEN-negative_NNP tumor_NN cells_NNS ,_, our_PRP$ study_NN
        has_VBZ focused_VBN on_IN the_DT regulation_NN of_IN endogenous_JJ PTEN_NNP in_IN
        anchorage-dependent_JJ mouse_NN and_CC human_JJ fibroblasts_NNS ._. We_PRP found_VBD
        that_IN upon_IN detachment_NN ,_, both_DT cell_NN lines_NNS exhibited_VBN increased_VBN
        levels_NNS of_IN PTEN_NNP expression_NN ,_, due_JJ to_TO the_DT transcriptional_NN
        activation_NN of_IN the_DT PTEN_NNP gene_NN ._. The_DT increased_VBN levels_NNS of_IN PTEN_NNP
        protein_NN resulted_VBD in_IN strongly_RB increased_VBN intracellular_NN PTEN_NNP
        phosphatase_NN activity_NN ._. Thus_RB ,_, our_PRP$ results_NNS revealed_VBD a_DT close_JJ
        correlation_NN between_IN the_DT disruption_NN of_IN cell-matrix_JJ
        interactions_NNS and_CC the_DT subsequent_JJ activation_NN of_IN the_DT PTEN_NNP
        phosphatase_NN ._. In_IN light_NN of_IN the_DT well-established_JJ
        growth-inhibitory_JJ effects_NNS exerted_VBN by_IN increased_VBN levels_NNS of_IN
        this_DT phosphatase_NN ,_, it_PRP is_VBZ reasonable_JJ to_TO conclude_VB that_IN this_DT
        activation_NN of_IN PTEN_NNP significantly_RB contributes_VBZ to_TO the_DT
        anchorage-dependent_JJ phenotype_NN ,_, i_NNP ._. e_SYM ._. ,_, to_TO the_DT inhibition_NN of_IN
        cell_NN proliferation_NN after_IN detachment_NN from_IN matrix_NN ._.
        It_PRP should_MD be_VB noted_VBN that_IN the_DT fibroblast_NN cells_NNS lines_NNS we_PRP
        used_VBD remain_VB fully_RB viable_JJ after_IN detachment_NN and_CC transfer_VB to_TO
        suspension_NN culture_NN [_NN 31_CD 43_CD ]_NN ._. This_DT is_VBZ in_IN contrast_NN to_TO most_JJS
        epithelial_NN cells_NNS which_WDT undergo_VBP anoikis_NNS ,_, i_NNP ._. e_SYM ._. ,_, apoptotic_JJ
        cell_NN death_NN after_IN the_DT disruption_NN of_IN cell-matrix_JJ interactions_NNS
        [_NN 45_CD ]_NN ._. It_PRP is_VBZ of_IN interest_NN that_IN some_DT anchorage-independent_JJ
        tumor_NN cells_NNS ,_, most_JJS of_IN which_WDT are_VBP of_IN epitheloid_NN origin_NN ,_, become_VB
        susceptible_JJ to_TO anoikis_NNS after_IN the_DT introduction_NN of_IN exogenous_JJ
        PTEN_NNP [_NN 23_CD 34_CD 35_CD 36_CD ]_NN ._. These_DT observations_NNS are_VBP in_IN line_NN with_IN
        the_DT established_VBN ability_NN of_IN PTEN_NNP to_TO down-regulate_JJ the_DT
        phosphatidylinositol_NN 3_CD -_: kinase_NN (_( PI_NNP 3_CD -_: K_NNP )_) /_NN PKB_NNP survival_NN pathway_NN
        [_NN 11_CD 46_CD ]_NN ._. The_DT absence_NN of_IN anoikis_NNS in_IN our_PRP$ two_CD cell_NN lines_NNS
        may_MD reflect_VB inherent_JJ cell_NN type_NN specific_JJ differences_NNS ,_, i_NNP ._. e_SYM ._. ,_,
        the_DT superior_JJ ability_NN of_IN fibroblasts_NNS to_TO survive_VB under_IN
        suspension_NN culture_NN conditions_NNS ._. One_PRP could_MD speculate_VB that_WDT
        increased_VBN levels_NNS of_IN PTEN_NNP might_MD favor_VB growth_NN arrest_NN in_IN
        fibroblasts_NNS versus_CC apoptosis_NNS in_IN epitheloid_NN cells_NNS ._.
        Furthermore_RB ,_, it_PRP appears_VBZ that_IN the_DT specific_JJ experimental_JJ or_CC
        physiological_JJ conditions_NNS of_IN cellular_JJ attachment_NN or_CC
        detachment_NN might_MD influence_VB the_DT precise_JJ function_NN of_IN PTEN_NNP in_IN
        these_DT processes_NNS ._. For_IN example_NN ,_, it_PRP was_VBD shown_VBN recently_RB that_IN
        the_DT reduction_NN of_IN PTEN_NNP expression_NN levels_NNS by_IN antisense_NN
        oligonucleotides_NNS in_IN a_DT colon_NN carcinoma_NN cell_NN line_NN generated_VBD
        differential_NN effects_NNS on_IN cell_NN adhesion_NN ,_, depending_VBG on_IN whether_IN
        the_DT cells_NNS were_VBD kept_VBN under_IN static_JJ or_CC hydrodynamic_JJ conditions_NNS
        of_IN fluid_JJ flow_NN [_NN 47_CD ]_NN ._.
        One_CD of_IN the_DT established_VBN in_IN vivo_NN substrates_NNS of_IN PTEN_NNP ,_, FAK_NNP ,_,
        is_VBZ known_VBN to_TO play_VB a_DT major_JJ role_NN in_IN growth-regulatory_JJ signal_NN
        transduction_NN initiated_VBN by_IN cell_NN surface_NN integrin_NN receptors_NNS [_NN
        48_CD 49_CD ]_NN ._. As_IN we_PRP observe_VBP a_DT correlation_NN between_IN increased_VBN
        PTEN_NNP activity_NN and_CC decreased_VBD levels_NNS of_IN FAK_NNP phosphorylation_NN
        (_( compare_VB Figure_NN 4_CD Band_NNP Figure_NNP 5_LS )_) ,_, it_PRP is_VBZ likely_JJ that_IN the_DT
        dephosphorylation_NN of_IN FAK_NNP in_IN response_NN to_TO the_DT disruption_NN of_IN
        cell-matrix_JJ interactions_NNS is_VBZ accomplished_VBN by_IN increased_VBN PTEN_NNP
        activity_NN ._. Such_JJ a_DT scenario_NN would_MD plausibly_RB explain_VB some_DT of_IN
        PTEN_NNP 's_POS growth-inhibitory_JJ effect_NN ._. Additional_JJ
        growth-inhibitory_JJ effects_NNS of_IN increased_VBN PTEN_NNP activity_NN are_VBP
        likely_JJ to_TO occur_VB through_IN the_DT stimulation_NN of_IN the_DT cell_NN cycle_NN
        inhibitor_NN p_NN 27_CD Kip_NNP 1_CD ._. This_DT protein_NN acts_NNS as_IN inhibitor_NN of_IN
        cyclin-dependent_JJ kinases_NNS (_( the_DT "_'' cell_NN cycle_NN engine_NN "_'' [_NN 50_CD ]_NN )_) ,_,
        and_CC its_PRP$ elevated_JJ expression_NN has_VBZ been_VBN consistently_RB
        demonstrated_VBN in_IN different_JJ cell_NN types_NNS after_IN the_DT disruption_NN
        of_IN cell-matrix_JJ interactions_NNS (_( compare_VB Figure_NN 1_CD and_CC [_NN 31_CD 32_CD 51_CD
        52_CD ]_NN )_) ._. Furthermore_RB ,_, p_NN 27_CD Kip_NNP 1_CD is_VBZ an_DT established_VBN target_NN of_IN
        PTEN_NNP signaling_VBG ,_, i_NNP ._. e_SYM ._. ,_, its_PRP$ activity_NN has_VBZ been_VBN found_VBN increased_VBN
        after_IN the_DT forced_VBN expression_NN of_IN exogenous_JJ PTEN_NNP [_NN 53_CD 54_CD 55_CD 56_CD
        ]_NN ._. In_IN combination_NN with_IN the_DT data_NNS presented_VBN in_IN this_DT
        manuscript_NN ,_, it_PRP therefore_RB appears_VBZ that_IN PTEN_NNP contributes_VBZ to_TO
        anchorage-dependent_JJ growth_NN control_NN by_IN a_DT two-fold_JJ approach_NN :_:
        the_DT dephosphorylation_NN of_IN the_DT signaling_VBG molecule_NN FAK_NNP in_IN
        combination_NN with_IN the_DT stimulation_NN of_IN the_DT cell_NN cycle_NN
        inhibitor_NN p_NN 27_CD Kip_NNP 1_CD ._.
      
      
        Conclusions_NNP
        In_IN view_NN of_IN PTEN_NNP 's_POS potent_JJ growth-inhibitory_JJ capacity_NN ,_, we_PRP
        conclude_VBP that_IN its_PRP$ induction_NN after_IN cell-matrix_JJ disruptions_NNS
        contributes_VBZ to_TO the_DT maintenance_NN of_IN the_DT anchorage-dependent_JJ
        phenotype_NN of_IN normal_JJ cells_NNS ._. The_DT underlying_VBG processes_VBZ involve_VB
        the_DT stimulation_NN of_IN expression_NN of_IN p_NN 27_CD Kip_NNP 1_CD and_CC the_DT
        dephosphorylation_NN of_IN FAK_NNP ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Materials_NNS
          HEMA_NNP (_( poly-_NN HEMA_NNP ;_: poly_RB (_( 2_CD -_: hydroxyethyl_NN methacrylate_NN )_) was_VBD
          obtained_VBN from_IN Sigma_NNP (_( St_NNP ._. Louis_NNP ,_, MO_NNP )_) and_CC dissolved_VBN in_IN
          ethanol_NN at_IN 10_CD mg_NN /_NN ml_NN ._.
        
        
          Cell_NNP lines_NNS and_CC culture_NN
          C_NNP 3_CD /_NN 10_CD T_NN 1_CD /_NN 2_CD mouse_NN fibroblasts_NNS were_VBD obtained_VBN from_IN the_DT
          American_NNP Tissue_NNP Culture_NNP Collection_NNP (_( ATCC_NNP ,_, Rockville_NNP ,_, MD_NNP )_) ._.
          MDAH_NNP human_JJ fibroblasts_NNS from_IN Li_NNP Fraumeni_NNP patients_NNS
          (_( p_NN 53_CD -_: negative_JJ )_) ,_, and_CC the_DT same_JJ cells_NNS stably_RB transfected_JJ
          with_IN a_DT tetracycline-regulated_JJ p_NN 53_CD expression_NN vector_NN
          (_( TR_NNP 9_CD -_: 7_CD )_) [_NN 42_CD ]_NN ,_, were_VBD obtained_VBN from_IN W_NNP ._. R_NN ._. Taylor_NNP and_CC G_NNP ._. R_NN ._.
          Stark_NNP (_( Cleveland_NNP Clinic_NNP Foundation_NNP ,_, Cleveland_NNP ,_, OH_NNP )_) ._. The_DT
          U_NNP 87_CD glioblastoma_NN tumor_NN cell_NN line_NN has_VBZ been_VBN described_VBN [_NN 57_CD
          ]_NN and_CC was_VBD obtained_VBN from_IN Webster_NNP K_NNP ._. Cavenee_NNP (_( UC_NNP San_NNP Diego_NNP ,_,
          La_NNP Jolla_NNP ,_, CA_NNP )_) ._.
          All_DT cells_NNS were_VBD maintained_VBN in_IN Dulbecco_NNP 's_POS modified_VBN
          Eagle_NNP 's_POS medium_NN (_( DMEM_NNP )_) supplemented_JJ with_IN 10_CD %_NN calf_NN serum_NN ,_,
          100_CD U_NNP /_NN ml_NN penicillin_NN ,_, and_CC 0_CD ._. 1_CD mg_NN /_NN ml_NN streptomycin_NN at_IN 37_CD °_NN C_NNP
          in_IN a_DT 5_CD %_NN CO_NNP 
          2_CD atmosphere_NN ._. For_IN the_DT disruption_NN of_IN
          cell-matrix_JJ interactions_NNS ,_, cells_NNS grown_VBN as_IN a_DT monolayer_NN were_VBD
          either_CC trypsinized_JJ or_CC scraped_JJ off_IN the_DT culture_NN dish_NN and_CC
          dispersed_VBD by_IN pipetting_VBG ._. Then_RB one_CD half_NN was_VBD seeded_VBN back_RB
          into_IN a_DT culture_NN dish_NN for_IN re-attachment_JJ ,_, the_DT other_JJ half_NN was_VBD
          cultured_JJ in_IN HEMA-coated_NNP plates_NNS which_WDT prevented_VBD the_DT
          attachment_NN of_IN cells_NNS [_NN 37_CD ]_NN ._.
        
        
          PTEN_NNP phosphatase_NN assays_NNS
          Phospho-tyrosine_NNP phosphatase_NN assays_NNS were_VBD performed_VBN
          similarly_RB to_TO previously_RB described_VBD protocols_NNS [_NN 14_CD 58_CD ]_NN ._.
          For_IN the_DT preparation_NN of_IN tyrosine-phosphorylated_JJ substrate_NN ,_,
          7_CD ×_NN 10_CD 6_CD HTC-IR_NNP cells_NNS [_NN 59_CD ]_NN were_VBD incubated_JJ with_IN medium_NN
          containing_VBG insulin_NN (_( 50_CD nM_NN /_NN ml_NN )_) and_CC lysed_JJ with_IN RIPA_NNP buffer_NN ._.
          Insulin_NNP receptor_NN was_VBD immunoprecipitated_JJ with_IN specific_JJ
          antibodies_NNS ,_, collected_VBN with_IN protein_NN A_DT sepharose_NN ,_, and_CC
          incubated_JJ with_IN polyGlu_NN 
          4_CD Tyr_NNP 
          1_CD peptides_NNS (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) in_IN
          the_DT presence_NN of_IN [_NN γ-_NN 32_CD P_NN ]_NN -_: ATP_NNP [_NN 14_CD ]_NN ._. After_IN completion_NN of_IN
          the_DT kinase_NN reaction_NN ,_, the_DT mix_NN was_VBD centrifuged_JJ and_CC the_DT
          phospho-peptide-containing_JJ supernatant_NN precipitated_VBD with_IN
          20_CD %_NN TCA_NNP (_( w_NN /_NN v_NN )_) ._. After_IN washing_VBG ,_, the_DT phospho-peptide_JJ was_VBD
          solubilized_JJ in_IN 30_CD mM_NN Tris_NNP pH_NN 8_CD ._. 0_CD ,_, and_CC aliquots_NNS were_VBD dried_VBN
          onto_IN DE_NNP 81_CD paper_NN (_( 1_CD ×_NN 1_CD cm_NN )_) ._.
          For_IN the_DT phosphatase_NN assays_NNS ,_, PTEN_NNP was_VBD
          immunoprecipitated_JJ from_IN cellular_JJ lysates_NNS using_VBG anti-_NN PTEN_NNP
          mouse_NN monoclonal_NN antibodies_NNS [_NN 44_CD ]_NN ,_, and_CC incubated_JJ with_IN
          the_DT substrate_NN on_IN DE_NNP 81_CD paper_NN for_IN 5_CD min_NN ._. at_IN room_NN
          temperature_NN ._. The_DT reaction_NN was_VBD stopped_VBN by_IN adding_VBG 75_CD mM_NN H_NNP 
          3_CD PO_NNP 
          4_CD (_( 5_CD ml_NN )_) ._. Both_DT the_DT released_VBN as_RB well_RB as_IN
          the_DT retained_VBN radioactivity_NN was_VBD determined_VBN with_IN a_DT
          scintillation_NN counter_NN ._.
        
        
          RNA_NNP analysis_NN
          Total_NNP RNA_NNP was_VBD isolated_VBN using_VBG the_DT guanidium_NN thiocyanate_NN
          method_NN [_NN 60_CD ]_NN ,_, followed_VBN by_IN poly_RB A_DT extraction_NN using_VBG oligo_NN
          dT_NN beads_NNS [_NN 61_CD ]_NN ._. Equal_NNP amounts_NNS of_IN each_DT RNA_NNP sample_NN were_VBD
          separated_JJ on_IN formaldehyde_NN /_NN agarose_NN gels_NNS and_CC transferred_VBN
          onto_IN nitrocellulose_NN membranes_NNS ._. For_IN hybridization_NN ,_,
          specific_JJ riboprobes_NNS were_VBD generated_VBN using_VBG T_NN 7_CD RNA_NNP
          polymerase_NN according_VBG to_TO manufacturer_NN 's_POS instructions_NNS ._. The_DT
          hybridization_NN was_VBD carried_VBN out_IN essentially_RB as_IN described_VBN [_NN
          62_CD ]_NN ._. After_IN hybridization_NN ,_, the_DT membranes_NNS were_VBD washed_VBN
          twice_RB at_IN 80_CD °_NN C_NNP in_IN 0_CD ._. 2_CD ×_NN SSPE_NNP and_CC 0_CD ._. 5_CD %_NN SDS_NNP for_IN 30_CD minutes_NNS ,_,
          and_CC subsequently_RB exposed_VBN to_TO Kodak_NNP X-AR_NNP autoradiographic_JJ
          film_NN ._. After_IN exposure_NN ,_, the_DT filters_NNS were_VBD stripped_VBN and_CC
          rehybridized_JJ in_IN order_NN to_TO confirm_VB that_IN equal_JJ amounts_NNS of_IN
          RNA_NNP were_VBD loaded_VBN in_IN each_DT lane_NN ._. For_IN this_DT purpose_NN ,_, two_CD
          probes_NNS were_VBD used_VBN ;_: one_CD was_VBD β-actin_JJ ,_, the_DT other_JJ was_VBD choA_NN ,_,
          which_WDT is_VBZ clone_NN A_DT of_IN a_DT group_NN of_IN highly_RB expressed_VBD mRNAs_NNS
          from_IN Chinese_JJ hamster_NN ovary_JJ (_( cho_NN )_) cells_NNS [_NN 40_CD ]_NN ._. The_DT
          quantitation_NN of_IN the_DT hybridized_JJ blots_NNS was_VBD performed_VBN using_VBG
          the_DT AMBIS_NNP Radioanalytic_NNP Imaging_NNP System_NNP (_( Analytical_NNP
          Development_NNP Corporation_NNP ,_, Colorado_NNP Springs_NNP ,_, CO_NNP )_) ._.
        
        
          Western_JJ blot_NN analysis_NN
          Total_JJ cell_NN lysates_NNS were_VBD prepared_VBN by_IN lysis_NNS of_IN cells_NNS
          with_IN RIPA_NNP buffer_NN [_NN 63_CD ]_NN ._. Thirty_NNP μg_NN of_IN each_DT sample_NN was_VBD
          processed_VBN by_IN Western_JJ blot_NN analysis_NN as_IN described_VBN [_NN 31_CD ]_NN ._.
          Antibodies_NNP against_IN cell_NN cycle-regulatory_JJ proteins_NNS as_RB well_RB
          as_IN those_DT against_IN focal_JJ adhesion_NN kinase_NN were_VBD purchased_VBN
          from_IN Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Inc_NNP ._. (_( Santa_NNP Cruz_NNP ,_, CA_NNP )_) ._.
          Monoclonal_NNP antibodies_NNS against_IN PTEN_NNP were_VBD generated_VBN and_CC
          used_VBN as_IN described_VBN previously_RB [_NN 44_CD ]_NN ._. The_DT secondary_JJ
          antibodies_NNS were_VBD coupled_VBN to_TO horseradish_NN peroxidase_NN ,_, and_CC
          were_VBD detected_VBN by_IN chemiluminescence_NN using_VBG the_DT SuperSignal_NNP ™_NN
          substrate_NN from_IN Pierce_NNP (_( Rockford_NNP ,_, MD_NNP )_) ._.
        
      
      
        Authors_NNP '_'' Contributions_NNP
        R-CW_NNP cultured_JJ the_DT cells_NNS and_CC performed_VBD the_DT expression_NN
        analysis_NN of_IN PTEN_NNP ._. XL_NNP performed_VBD some_DT of_IN the_DT Western_JJ blots_NNS
        and_CC the_DT in_IN vitro_NN phosphatase_NN activity_NN studies_NNS ._. MB_NNP performed_VBD
        experiments_NNS for_IN the_DT revised_VBN version_NN of_IN the_DT manuscript_NN ._. AHS_NNP
        conceived_VBD of_IN the_DT study_NN ,_, and_CC participated_VBD in_IN its_PRP$ design_NN and_CC
        coordination_NN ._. All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ
        manuscript_NN ._.
      
    
  
